{"id":28054,"date":"2023-01-11T15:40:39","date_gmt":"2023-01-11T10:10:39","guid":{"rendered":"http:\/\/finservwealth.com\/marksans-pharma-spurts-to-52-week-high-on-share-allotment-to-promoter\/"},"modified":"2023-01-11T15:40:39","modified_gmt":"2023-01-11T10:10:39","slug":"marksans-pharma-spurts-to-52-week-high-on-share-allotment-to-promoter","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/marksans-pharma-spurts-to-52-week-high-on-share-allotment-to-promoter\/","title":{"rendered":"Marksans Pharma spurts to 52-week high on share allotment to promoter"},"content":{"rendered":"<p> The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia<\/p><div id=\"finse-671930077\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/marksans-pharma-spurts-to-52-week-highshare-allotment-to-promoter_16802201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/marksans-pharma-spurts-to-52-week-highshare-allotment-to-promoter_16802201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/marksans-pharma-spurts-to-52-week-highshare-allotment-to-promoter_16802201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/marksans-pharma-spurts-to-52-week-highshare-allotment-to-promoter_16802201.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-28054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/s\/sensex_nifty-marketup_sensexup-Niftyup-1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/28054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=28054"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/28054\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=28054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=28054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=28054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}